Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitiligo Information Resource database v3.

NPJ systems biology and applications·2026
Same author

Systems biology-driven analysis of obesity-associated genes with transcript mapping and post-translational modification annotations.

Biochemical and biophysical research communications·2026
Same author

mTOR Signalling in Neurodegenerative Disorders: Unveiling Key Factors, Mechanistic Insights, and Possible Therapeutic Interventions.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology·2026
Same author

From determinism to probability: integrating artificial intelligence into male infertility genetics.

Journal of assisted reproduction and genetics·2026
Same author

A concept-enhanced, knowledge graph-guided framework for interpretable PCOS prediction: a case study in explainable biomedical artificial intelligence.

Reproduction, fertility, and development·2026
Same author

Genomic alterations and their correlation with metabolic-related genes in lung cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Related Experiment Video

Updated: Dec 5, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.0K

Stem Cell Based Preclinical Drug Development and Toxicity Prediction.

Dhruv Kumar1, Prakash Baligar1, Rajpal Srivastav2

  • 1Amity Institute of Molecular Medicine & Stem Cell Research, Amity University, Noida, Uttar Pradesh 201313, India.

Current Pharmaceutical Design
|October 20, 2020
PubMed
Summary

Stem cell toxicity prediction offers a robust alternative to animal models, overcoming interspecies variation issues. Advanced methods like organ-on-a-chip enhance drug safety screening for new chemical entities.

Keywords:
Stem celldrug development.high throughput screeninginduced pluripotent stem cellorganoidstoxicity prediction

More Related Videos

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations
05:49

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Published on: October 26, 2011

48.3K
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

3.3K

Related Experiment Videos

Last Updated: Dec 5, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.0K
Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations
05:49

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Published on: October 26, 2011

48.3K
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

3.3K

Area of Science:

  • Biotechnology
  • Toxicology
  • Drug Development

Background:

  • Drug development faces significant attrition due to unexpected adverse effects identified late in clinical trials.
  • Traditional in vitro and in vivo toxicity models suffer from limitations, particularly poor extrapolation of results due to interspecies variations.
  • There is a critical need for advanced, reliable drug screening platforms to predict chemical toxicity early in development.

Purpose of the Study:

  • To review the advancements in stem cell-based toxicity prediction methods for drug development.
  • To highlight the utility of various stem cell types, including pluripotent stem cells and organoids, in toxicity assessment.
  • To discuss the integration of emerging technologies like organ-on-a-chip for high-throughput toxicity screening.

Main Methods:

  • Review of literature on stem cell applications in toxicity testing.
  • Discussion of the embryonic stem cell test (EST) and its evolution.
  • Exploration of induced pluripotent stem cells (iPSCs) and organoid models for predictive toxicology.
  • Examination of microfluidics and tissue engineering for organ-on-a-chip assays.

Main Results:

  • Stem cells provide robust platforms to study the impact of new chemical entities on specific cell types and organs.
  • Pluripotent stem cells and their derivatives enable evaluation of drug-induced cellular function modulation.
  • Organ-on-a-chip technologies facilitate high-throughput screening for chemical and drug toxicity.

Conclusions:

  • Stem cell-based toxicity prediction significantly improves drug safety assessment by overcoming limitations of traditional models.
  • The use of pluripotent stem cells, iPSCs, and organoids represents a paradigm shift in predictive toxicology.
  • Integration of advanced technologies like organ-on-a-chip promises more accurate and efficient drug development pipelines.